These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9707262)

  • 1. Cardiovascular risk continuum: implications of insulin resistance and diabetes.
    Hsueh WA; Law RE
    Am J Med; 1998 Jul; 105(1A):4S-14S. PubMed ID: 9707262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and atheroma. 20-yr perspective.
    Stout RW
    Diabetes Care; 1990 Jun; 13(6):631-54. PubMed ID: 2192848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and lipid metabolism.
    Howard BV
    Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus].
    Fábryová L; Cagán S
    Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis.
    Fujii S; Goto D; Zaman T; Ishimori N; Watano K; Kaneko T; Okada H; Makiguchi M; Nakagawa T; Kitabatake A
    J Atheroscler Thromb; 1998; 5(2):76-81. PubMed ID: 10855561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance.
    Sunayama S; Watanabe Y; Ohmura H; Sawano M; Shimada K; Mokuno H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Sep; 146(1):187-93. PubMed ID: 10487503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
    Reaven GM
    Diabetes Obes Metab; 2002 Jan; 4 Suppl 1():S13-8. PubMed ID: 11843950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
    Demant T
    Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
    Reusch JE
    Am J Cardiol; 2002 Sep; 90(5A):19G-26G. PubMed ID: 12231075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.